These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38350430)

  • 1. Evaluation of a Multimodal Stress Management and Comprehensive Lifestyle Modification Program on Quality of Life and Gastrointestinal Symptoms in Patients with Crohn's Disease: A Randomized Controlled Pilot Trial with 9-Month Follow-Up.
    Bauer N; Löffler C; Oeznur O; Uecker C; Schlee C; Adamczyk A; Elsenbruch S; Pfuhlmann K; Reissmann R; Westendorf A; Keil T; Langhorst J
    Digestion; 2024; 105(3):201-212. PubMed ID: 38350430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mind-body-medicine and comprehensive lifestyle-modification in patients with Crohn's disease-Feasibility of a randomized controlled trial under pandemic circumstances.
    Bauer N; Löffler C; Öznur Ö; Uecker C; Keil T; Langhorst J
    Front Integr Neurosci; 2022; 16():960301. PubMed ID: 36081609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial.
    Boye B; Lundin KE; Jantschek G; Leganger S; Mokleby K; Tangen T; Jantschek I; Pripp AH; Wojniusz S; Dahlstroem A; Rivenes AC; Benninghoven D; Hausken T; Roseth A; Kunzendorf S; Wilhelmsen I; Sharpe M; Blomhoff S; Malt UF; Jahnsen J
    Inflamm Bowel Dis; 2011 Sep; 17(9):1863-73. PubMed ID: 21287660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up.
    Langhorst J; Mueller T; Luedtke R; Franken U; Paul A; Michalsen A; Schedlowski M; Dobos GJ; Elsenbruch S
    Scand J Gastroenterol; 2007 Jun; 42(6):734-45. PubMed ID: 17505996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing management of Crohn's disease within a project management framework: results of a pilot study.
    Keefer L; Doerfler B; Artz C
    Inflamm Bowel Dis; 2012 Feb; 18(2):254-60. PubMed ID: 21351218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn's disease.
    Zhou S; Huang Z; Hou W; Lin Y; Yu J
    Inflamm Res; 2024 Feb; 73(2):199-209. PubMed ID: 38168701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lifestyle modification on coronary artery calcium progression and prognostic factors in coronary patients--3-year results of the randomized SAFE-LIFE trial.
    Lehmann N; Paul A; Moebus S; Budde T; Dobos GJ; Michalsen A
    Atherosclerosis; 2011 Dec; 219(2):630-6. PubMed ID: 21944697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.
    Wynne B; McHugh L; Gao W; Keegan D; Byrne K; Rowan C; Hartery K; Kirschbaum C; Doherty G; Cullen G; Dooley B; Mulcahy HE
    Gastroenterology; 2019 Mar; 156(4):935-945.e1. PubMed ID: 30452919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingested matter affects intestinal lesions in Crohn's disease.
    Bartel G; Weiss I; Turetschek K; Schima W; Püspök A; Waldhoer T; Gasche C
    Inflamm Bowel Dis; 2008 Mar; 14(3):374-82. PubMed ID: 17932967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imagine HEALTH: results from a randomized pilot lifestyle intervention for obese Latino adolescents using Interactive Guided ImagerySM.
    Weigensberg MJ; Lane CJ; Ávila Q; Konersman K; Ventura E; Adam T; Shoar Z; Goran MI; Spruijt-Metz D
    BMC Complement Altern Med; 2014 Jan; 14():28. PubMed ID: 24433565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle changes for treating psoriasis.
    Ko SH; Chi CC; Yeh ML; Wang SH; Tsai YS; Hsu MY
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011972. PubMed ID: 31309536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
    Colombel JF; Panaccione R; Bossuyt P; Lukas M; Baert F; Vaňásek T; Danalioglu A; Novacek G; Armuzzi A; Hébuterne X; Travis S; Danese S; Reinisch W; Sandborn WJ; Rutgeerts P; Hommes D; Schreiber S; Neimark E; Huang B; Zhou Q; Mendez P; Petersson J; Wallace K; Robinson AM; Thakkar RB; D'Haens G
    Lancet; 2017 Dec; 390(10114):2779-2789. PubMed ID: 29096949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's disease.
    Seeger WA; Thieringer J; Esters P; Allmendinger B; Stein J; Schulze H; Dignass A
    United European Gastroenterol J; 2020 Aug; 8(7):804-813. PubMed ID: 32580666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The INSPIRE study: are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?
    Boye B; Jahnsen J; Mokleby K; Leganger S; Jantschek G; Jantschek I; Kunzendorf S; Benninghoven D; Wilhelmsen I; Sharpe M; Blomhoff S; Malt UF; Lundin KE
    Inflamm Bowel Dis; 2008 May; 14(5):680-6. PubMed ID: 18509900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
    Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
    Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.
    Yanai H; Levine A; Hirsch A; Boneh RS; Kopylov U; Eran HB; Cohen NA; Ron Y; Goren I; Leibovitzh H; Wardi J; Zittan E; Ziv-Baran T; Abramas L; Fliss-Isakov N; Raykhel B; Gik TP; Dotan I; Maharshak N
    Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):49-59. PubMed ID: 34739863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.